Neurology Central

EAN 2017: Cannabinoids suitable for migraine prophylaxis

A study presented at the Congress of the European Academy of Neurology (Amsterdam, The Netherlands, 24–27 June 2017) has confirmed that cannabinoids are suitable for migraine prophylaxis. The study – led by Maria Nicolodi (Interuniversity Center, Florence, Italy) – investigated the use of cannabinoids for migraine prevention as well as the treatment of migraine and acute cluster headaches. Interestingly, findings indicated that cannabinoids are only effective at treating acute cluster headaches in patients who have suffered from migraine in childhood.
Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.